Home
Faculty of Medicine

News archive for Faculty of Medicine

This years Annual Research Presentations by the Research School in Clinical Medicine.
Welcome to the digital and free SDG Conference in Bergen 2024! The theme is Take a look at the programme and register today.
The Pandemic Centre participated in a Round table discussion: “Strengthening the capacity and ensuring the protection of vulnerable migrants, asylum seekers and refugees” organized by INTERSOS Hellas
The annual Christmas Seminar took place at hotel Terminus Dec 11. The PhD fellows Anja Linde and Marit Sandberg chaired the meeting, here together with Edda Bahlmann PhD from Hamburg University
Exciting news is brewing in our research community! We’re thrilled to announce that the work by a researcher at the Tissue Engineering group, Shuntaro Yamada, has been featured as the Best Scientific Image of the Month on Nature.
In new study published by researchers at the Department for Global Public Health and Primary Care they found a bidirectional relationship between C-section and the time it takes for a couple to conceive.
UiB research reveals that around 20 per cent of all cases of the most severe form of breast cancer may arise from the small group of normal tissue cells carrying an epimutation of a specific gene.
CCBIO PhD candidate Marta Espevold Hjelmeland in the Krakstad group spends the second year of her PhD program in Boston.
The regional health authority Helse Vest’s Research Award 2023 goes to Professor Lars Andreas Akslen and CCBIO for ground-breaking research on cancer biomarkers. Akslen has also been subject to another prestigious recognition this fall, as he was recently elected as member of the Academia Europaea.
Mari Kyllesø Halle received a frame allocation of NOK 8 million in the Researcher Projects 2023 call from the Norwegian Cancer Association, for the project "Decoding the Landscape of Cancer Vulnerabilities in high-risk Cervical Carcinomas to detect new treatment strategies." CCBIO is proud to see this CCBIO Masterclass alumna as a project leader for the first time.
Emmet McCormack will be part of the new COST Action IMMUNO-model, where a network of scientists involved in the development and implementation of preclinical models evaluating the response and toxicity induced by immunotherapies, is challenged to expand our knowledge in their mechanisms of action and improve the survival and quality of life of cancer patients.
Did you miss Thomas Herzfelder Hansens presentation investigating the impact on engineering, manufacturing, commissioning, and farm-farm interaction due to the ongoing race for bigger turbines? Watch it here!